These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 3126060)
21. Shifting of the penicillin binding proteins that are the target for inhibition by beta-lactams as a likely mechanism of resistance to antibiotics during therapy. Satta G; Canepari P; Maurici R; Pompei R; Marcialis MA Chemioterapia; 1985 Feb; 4(1):113-5. PubMed ID: 3986940 [TBL] [Abstract][Full Text] [Related]
22. Role of permeability barriers in resistance to beta-lactam antibiotics. Nikaido H Pharmacol Ther; 1985; 27(2):197-231. PubMed ID: 2412244 [No Abstract] [Full Text] [Related]
23. Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria. Dalhoff A; Nasu T; Okamoto K Chemotherapy; 2003 Jul; 49(4):172-83. PubMed ID: 12886052 [TBL] [Abstract][Full Text] [Related]
24. Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Chambers HF; Moreau D; Yajko D; Miick C; Wagner C; Hackbarth C; Kocagöz S; Rosenberg E; Hadley WK; Nikaido H Antimicrob Agents Chemother; 1995 Dec; 39(12):2620-4. PubMed ID: 8592990 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of resistance of enterococci to beta-lactam antibiotics. Fontana R; Canepari P; Lleò MM; Satta G Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):103-5. PubMed ID: 2180705 [TBL] [Abstract][Full Text] [Related]
26. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus. Fasola EL; Fasching CE; Peterson LR J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469 [TBL] [Abstract][Full Text] [Related]
27. Structural and mechanistic aspects of evolution of beta-lactamases and penicillin-binding proteins. Massova I; Mobashery S Curr Pharm Des; 1999 Nov; 5(11):929-37. PubMed ID: 10539997 [TBL] [Abstract][Full Text] [Related]
28. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases. Yang Y; Bhachech N; Bush K J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785 [TBL] [Abstract][Full Text] [Related]
29. [Comparative characteristics of penicillin-binding proteins of representatives of the genus Streptomyces]. Griaznova NS; Subbotina NA; Beliavskaia IV; Taisova AS; Afonin VI Antibiot Khimioter; 1988 Mar; 33(3):223-8. PubMed ID: 3132120 [TBL] [Abstract][Full Text] [Related]
30. Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Clairoux N; Picard M; Brochu A; Rousseau N; Gourde P; Beauchamp D; Parr TR; Bergeron MG; Malouin F Antimicrob Agents Chemother; 1992 Jul; 36(7):1504-13. PubMed ID: 1510447 [TBL] [Abstract][Full Text] [Related]
31. Interaction of beta-lactam antibiotics with the penicillin-binding proteins of penicillin-resistant Streptococcus pneumoniae. Ikeda F; Yokota Y; Ikemoto A; Teratani N; Shimomura K; Kanno H Chemotherapy; 1995; 41(3):159-64. PubMed ID: 7656660 [TBL] [Abstract][Full Text] [Related]
32. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents. Gootz T; Retsema J; Girard A; Hamanaka E; Anderson M; Sokolowski S Antimicrob Agents Chemother; 1989 Aug; 33(8):1160-6. PubMed ID: 2679370 [TBL] [Abstract][Full Text] [Related]
33. Interactions of Yersinia pestis penicillin-binding proteins with beta-lactam antibiotics. Ferreira RC; Park JT; Camelo D; De Almeida DF; Ferreira LC Antimicrob Agents Chemother; 1995 Aug; 39(8):1853-5. PubMed ID: 7486931 [TBL] [Abstract][Full Text] [Related]
34. Penicillin binding proteins, beta-lactams, and lactamases: offensives, attacks, and defensive countermeasures. Koch AL Crit Rev Microbiol; 2000; 26(4):205-20. PubMed ID: 11192022 [TBL] [Abstract][Full Text] [Related]
35. Studies on penem antibiotics. II. In vitro activity of SUN5555, a new oral penem. Nishino T; Maeda Y; Ohtsu E; Koizuka S; Nishihara T; Adachi H; Okamoto K; Ishiguro M J Antibiot (Tokyo); 1989 Jun; 42(6):977-88. PubMed ID: 2661512 [TBL] [Abstract][Full Text] [Related]
36. The mode of action of Sch 34343: affinity for the penicillin binding proteins of Escherichia coli K-12 and Bacteroides fragilis. Piddock LJ; Wise R J Antimicrob Chemother; 1985 Jun; 15 Suppl C():5-14. PubMed ID: 3897174 [TBL] [Abstract][Full Text] [Related]
37. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Okamoto K; Gotoh N; Nishino T Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209 [TBL] [Abstract][Full Text] [Related]
38. [Penicillin-binding proteins. Their enzymatic activity and properties]. Griaznova NS; Subbotina NA Antibiot Med Biotekhnol; 1986 Jul; 31(7):487-98. PubMed ID: 3532933 [No Abstract] [Full Text] [Related]
40. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Neu HC Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]